| Human CLEC2D Protein (LTP10368) |
| LTP10368 |
| 100ug |
|
$519 In stock |
| C-type lectin domain family 2, member D (CLEC2D) is implicated in the immune response. Pre-eclampsia and HIV infection have opposing immune responses. The contrasting expression of CLEC2D in HIV infection and pre-eclampsia is demonstrative of the immunosuppressive and pro-inflammatory roles of the respective pathologies. However, this implication may be confounded by highly active anti-retroviral treatment (HAART). |
| Recombinant Human CLEC2D Protein is expressed from Expi293 with hFc tag and Avi tag at the N-terminal. It contains Arg60-Val191. |
| CLEC2D |
| Human |
| Q9UHP7-1 |
| Arg60-Val191 |
| The protein has a predicted MW of 59.1 kDa. Due to glycosylation, the protein migrates to 72-78 kDa based on the Tris-Bis PAGE result. |
| 0 |
| N-hFc-Avi |
| Expi293 |
| > 95% as determined by Tris-Bis PAGE; > 95% as determined by HPLC |
| Less than 1EU per ug by the LAL method. |
| Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as a protectant before lyophilization. |
| Reconstituted protein stable at -80 C for 12 months, 4 C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
| Shipped at ambient temperature. |
| Centrifuge tubes before opening. Reconstituting to a concentration of more than 100 ug/ml is recommended. Dissolve the lyophilized protein in distilled water. |
| ![Human CLEC2D Protein (LTP10368)](/peptide-product/images/protein-products/LTP10368/20210809173558.png) |